CLC Number:
| [1] [s.n.] Clinical lectures on medicine delivered at the Hôtel-Dieu, Paris[J]. Br Foreign Med Chir Rev, 1864, 33(65): 45-54. [2] Tateo S, Mereu L, Salamano S, et al. Ovarian cancer and venous thromboembolic risk[J]. Gynecol Oncol, 2005, 99(1): 119-125. [3] Ikushima S, Ono R, Fukuda K, et al. Trousseaus syndrome: cancer-associated thrombosis[J]. Jpn J Clin Oncol, 2016, 46(3): 204-208. [4] Yuan Z, Cao D, Yu M, et al. Importance of standard treatment in prognosis of patients with ovarian cancer and associated cerebral infarction[J]. Clin Interv Aging, 2020, 15: 151-157. doi: 10.2147/CIA.S229236. [5] Takasaki K, Miyamoto M, Takano M, et al. Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma[J]. Int J Clin Oncol, 2019, 24(10): 1273-1283. [6] Duska LR, Garrett L, Henretta M, et al. When ‘never-events’ occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes[J]. Gynecol Oncol, 2010, 116(3): 374-377. [7] Takano H, Nakajima K, Nagayoshi Y, et al. Clinical associations of Trousseaus syndrome associated with cerebral infarction and ovarian cancer[J]. J Gynecol Oncol, 2018, 29(5): e67. doi: 10.3802/jgo.2018.29.e67. [8] 杨星昱,陶定波,申敬顺,等. 卵巢恶性肿瘤并发脑梗死一例及其机理分析[J]. 中华脑血管病杂志(电子版), 2013, 7(3): 12-14. |
| [1] | WANG Moulong, CHEN Yongkun, XING Deguang, QU Liangsuo, WANG Chengwei. A clinical analysis of transcranial Doppler in predicting delayed cerebral ischemia after ruptured aneurysm surgery [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 38-41. |
| [2] | LU Heng, LIU Yanguo, LI Shuguang, CHEN Xiaokang, TIAN Qi, YI Cuihua, WANG Xiuwen. Regulation of epithelial ovarian carcinoma SKOV-3 cell migration by YKL-40 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 33-38. |
| [3] | ZHAO Lu, JIAO Jun, ZHANG Teng, JIAO Xinlin, CUI Baoxia. Expression of LXRα in ovarian carcinoma and effects of T0901317 on SKOV3 cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 49-53. |
| [4] | ZHAO Yunxia, SONG Jing, ZHANG Cancan, LIN Xueyan, WEI Wei, TIAN Yongjie. CXXC4 promotes sensitivity to chemotherapy drugs in epithelial ovarian cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 24-29. |
| [5] | XU Zhihong, WU Xiaohua, YAO Tiezhu, WANG Xiaoxiang, DUAN Xiaoyang, SHI Jian. Relationship between mir-99a expression and prognosis of epithelial ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 77-80. |
| [6] | ZHANG Chunxia, ZOU Cunhua, SONG Dongdong, YU Jiang. Effects of P38 mitogen-activated protein kinase signal pathway on the expression of urokinase-type plasminogen activator in ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 68-74. |
| [7] | LÜ Shuqing, WEI Wei, ZHANG Cancan, TIAN Yongjie. Mechanism of HGF/PARP-1 signaling pathway regulating invasion and metastasis of ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 1-7. |
| [8] | FU Wei1, GAO Wenjuan2, ZHANG Zhimian1, QU Xun2, ZHAO Yuxia3. Regulation of vascular endothelial growth factor receptors expression in SKOV3 cells by basil polysaccharide and its effect on SKOV3 cell invasion [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 39-43. |
| [9] | LI Yan, WEI Wei, LV Shuqing, TIAN Yongjie. Effects of PARP-1 on angiogenesis of ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 97-101. |
| [10] | JIA Zong-yang, ZHANG Xiang-ning, JIN Yan-hui, WEI Mei-ling. Effects of PD98059 combined with cisplatin derivative on human ovarian carcinoma cell SKOV3 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 27-32. |
| [11] | DING Bai-juan, ZHANG You-zhong, L Chang-shuai, JIANG Kan, LIU Hong-li. Effects of TMPyP4-PDT on human cervical cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(11): 53-57. |
| [12] | ZHANG Jing-jing1, WANG Zhe1, TIAN Yong-jie1, ZHANG Jie2. Effects of PJ34 on growth activity and cisplatin resistance of ovarian cancer C13* cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(1): 46-50. |
| [13] |
LIU Min1,2， WANG Li2, ZHOU Ting2， RONG Feng-nian2.
Association between PR/AR gene polymorphisms and susceptibility to epithelial ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(9): 144-148. |
| [14] | KANG Ma-fei, BU Qing, LIU Ying, LUO Mei-qing， LIAO Li-li, TU Jiang-jiang. Pemetrexed alone or in combination with nedaplatin in recurrence and carboplatin/paclitaxel resistance advanced epithelial ovarian carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(5): 122-124. |
| [15] | KAN Yan-yan1, ZHANG Jing-jing1, WANG Zhe1, TIAN Yong-jie1, QI Xiao-xia2, ZHANG Jie3. Effect of reduced expression of PARP-1 by RNA interference on cisplatin-resistance and proliferation in the ovarian cancer cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 52-56. |
|
